Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Treats Adults

Siva K Suryadevara, MD

Cardiologist Interventional Cardiologist

Cardiologist, Interventional Cardiologist

4.8 /5 679 ratings
Photo of Siva K Suryadevara

Research at a glance

Top areas of exploration

  • Platelet Aggregation Inhibitors , 16 publications
  • Ticagrelor , 12 publications
  • Clopidogrel , 11 publications
  • Purinergic P2Y Receptor Antagonists , 10 publications

Research activity

31 publications

632 citations

Why is this important?

My publications

31 publications

2024

P2Y12 Inhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC-2 Study.

JACC. Cardiovascular interventions

PubMed Publisher's site

2024

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.

Thrombosis and haemostasis

PubMed Publisher's site

2023

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.

JACC. Cardiovascular interventions

PubMed Publisher's site

2023

Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

PubMed Publisher's site

2023

Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study.

JACC. Cardiovascular interventions

PubMed Publisher's site